The Influence of Sexual Behavior and Demographic Characteristics in the Expression of HPV-Related Biomarkers in a Colposcopy Population of Reproductive Age Greek Women.
CIN
HPV
HPV DNA
biomarkers
colposcopy
condoms
human papillomavirus
lifestyle
mRNA E6 and E7
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
26 Jul 2021
26 Jul 2021
Historique:
received:
02
06
2021
revised:
18
07
2021
accepted:
20
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Despite the significant scientific evolution in primary and secondary cervical cancer prevention in the battle started by George Papanicolaou in the previous century, global cervical cancer mortality rates remain disappointing. The widespread implementation of HPV-related molecular markers has paved the way to tremendous developments in cervical cancer screening, with the transition from cytological approach to the more accurate and cost-effective HPV testing modalities. However, the academic audience and different health systems have not yet adopted a universal approach in screening strategies, and even artificial intelligence modalities have been utilized from the multidisciplinary scientific armamentarium. Combination algorithms, scoring systems as well as artificial intelligent models have been so far proposed for cervical screening and management. The impact of sexual lifestyle inherently possesses a key role in the prevalence of HPV-related biomarkers. This study aimed to investigate any possible influence of sexual behavior and demographic characteristics in the expression of HPV-related biomarkers in a colposcopy population from October 2016 to June 2017, and corroborated the determining role of age at fist intercourse; the older the age, the lower the probability for DNA positivity. Multivariate analysis illustrated additionally that a number of sexual partners exceeding 4.2 was crucial, with women with ≤5 partners being approximately four times less likely to harbor a positive HPV DNA test (
Identifiants
pubmed: 34439947
pii: biology10080713
doi: 10.3390/biology10080713
pmc: PMC8389230
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 2002 Mar 30;359(9312):1093-101
pubmed: 11943256
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101621
pubmed: 31430562
Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):115-20
pubmed: 18971782
J Clin Virol. 2006 Jul;36(3):189-93
pubmed: 16690350
Cancer Res. 2010 Nov 1;70(21):8569-77
pubmed: 20978200
PLoS One. 2014 Jan 03;9(1):e82416
pubmed: 24404130
Expert Rev Anticancer Ther. 2021 Jul;21(7):781-794
pubmed: 33663309
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27
pubmed: 23519301
APMIS. 2009 Jan;117(1):22-7
pubmed: 19161533
Int J Gynecol Cancer. 2011 Jan;21(1):79-85
pubmed: 21330832
Gynecol Oncol. 2016 Apr;141(1):29-35
pubmed: 27016226
PLoS One. 2015 Mar 20;10(3):e0119755
pubmed: 25793281
Biomed Res Int. 2014;2014:341483
pubmed: 24812614
J Infect Dis. 2002 Aug 15;186(4):462-9
pubmed: 12195372
J Biomed Biotechnol. 2012;2012:303192
pubmed: 23093840
Womens Health (Lond). 2014 Mar;10(2):115-8
pubmed: 24601801
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Lancet. 2002 Mar 30;359(9312):1085-92
pubmed: 11943255
Expert Opin Med Diagn. 2009 Mar;3(2):123-31
pubmed: 23485159
Clin Microbiol Infect. 2011 Aug;17(8):1185-8
pubmed: 21595788
Acta Obstet Gynecol Scand. 2014 Feb;93(2):194-200
pubmed: 24175665
Oncol Lett. 2018 Sep;16(3):3833-3841
pubmed: 30127996
Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:2-13
pubmed: 28964706
Cytopathology. 2002 Feb;13(1):4-10
pubmed: 11985563
Ann N Y Acad Sci. 2010 Sep;1205:57-68
pubmed: 20840254
Cancer Causes Control. 2003 Nov;14(9):805-14
pubmed: 14682438
In Vivo. 2020 May-Jun;34(3):1445-1449
pubmed: 32354944
Eur J Gynaecol Oncol. 2011;32(1):54-61
pubmed: 21446326
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252
Gynecol Oncol. 2011 Sep;122(3):505-8
pubmed: 21665253
Eur J Gynaecol Oncol. 2011;32(2):178-81
pubmed: 21614908
Gynecol Oncol. 2011 Apr;121(1):49-53
pubmed: 21194734
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Anticancer Res. 2018 May;38(5):3079-3084
pubmed: 29715143
Clin Lab Med. 2003 Sep;23(3):585-603
pubmed: 14560530
Eur J Gynaecol Oncol. 2011;32(2):150-2
pubmed: 21614901
Bioanalysis. 2013 Nov;5(21):2697-711
pubmed: 24180508
Anticancer Res. 2012 Sep;32(9):4141-5
pubmed: 22993375
Clin Microbiol Infect. 2008 Jun;14(6):619-21
pubmed: 18384392
J Low Genit Tract Dis. 2017 Jul;21(3):184-188
pubmed: 28514239
Rev Obstet Gynecol. 2008 Summer;1(3):122-8
pubmed: 19015763
Gynecol Oncol. 2006 Nov;103(2):463-6
pubmed: 16626791
Cancers (Basel). 2021 Apr 01;13(7):
pubmed: 33915878
Ann Intern Med. 2011 Nov 15;155(10):698-705, W216
pubmed: 22006929
Cancers (Basel). 2020 May 05;12(5):
pubmed: 32380733